HCPC
PFE icon

Hamilton Capital Partners (Canada)’s Pfizer PFE Stock Holding History

Hamilton Capital Partners (Canada)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.71M Buy
278,825
+41,017
+17% +$1.07M 0.19% 97
2026
Q1 		$6.68M Buy
237,808
+14,098
+6% +$375K 0.22% 71
2025
Q4 		$5.57M Buy
223,710
+27,590
+14% +$696K 0.2% 91
2025
Q3 		$5M Buy
196,120
+4,827
+3% +$119K 0.21% 86
2025
Q2 		$4.64M Buy
191,293
+35,616
+23% +$831K 0.24% 85
2025
Q1 		$3.94M Buy
155,677
+22,082
+17% +$578K 0.25% 88
2024
Q4 		$3.54M Sell
133,595
-15,583
-10% -$423K 0.26% 81
2024
Q3 		$4.32M Sell
149,178
-22,798
-13% -$665K 0.37% 70
2024
Q2 		$4.81M Buy
171,976
+9,704
+6% +$267K 0.52% 60
2024
Q1 		$4.5M Buy
+162,272
New +$4.5M 0.55% 62

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Hamilton Capital Partners (Canada)'s PFE Position: Q2 2026 in Review

Hamilton Capital Partners (Canada) increased its Pfizer (PFE) stake by 17% in Q2 2026, buying an estimated $1.07M and bringing the position to 278,825 shares worth $6.71M. The position accounts for 0.19% of the portfolio, ranked #97.

Hamilton Capital Partners (Canada) first reported a position in PFE in Q1 2024 and has held it in 10 quarters since. 2,713 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hamilton Capital Partners (Canada) held 278,825 shares of Pfizer worth $6.71M as of Q2 2026.
  • Hamilton Capital Partners (Canada) bought 41,017 Pfizer shares in Q2 2026, an estimated $1.07M.
  • Pfizer made up 0.19% of Hamilton Capital Partners (Canada)'s portfolio in Q2 2026, its #97 holding.
  • Hamilton Capital Partners (Canada) first reported a position in Pfizer in Q1 2024 and has held it in 10 quarters since.
  • 2,713 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hamilton Capital Partners (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.